Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Contrast sensitivity in Parkinson's disease.

Literature DB >> 3736881

Contrast sensitivity in Parkinson's disease.

C Bulens, J D Meerwaldt, G J van der Wildt, C J Keemink.

Abstract

We studied contrast-sensitivity function in 39 patients with Parkinson's disease. Sixty-four percent of the patients showed contrast-sensitivity loss in one or both eyes. The abnormality was not related to the first symptom or the severity of disease. Sensitivity loss at intermediate frequencies (notch loss) in 30% of the "affected" eyes suggested a cortical component. These findings support the belief that there is a widespread neurotransmitter deficiency in Parkinson's disease.

Entities: Disease Species

Mesh：

Year: 1986 PMID： 3736881 DOI： 10.1212/wnl.36.8.1121

Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910

Keyword Cloud
Cited

12 in total

1. Bayesian adaptive estimation of the contrast sensitivity function: the quick CSF method.

Authors: Luis Andres Lesmes; Zhong-Lin Lu; Jongsoo Baek; Thomas D Albright
Journal: J Vis Date: 2010-03-30 Impact factor: 2.240

2. Visual contrast sensitivity in drug-induced Parkinsonism.

Authors: C Bulens; J D Meerwaldt; G J van der Wildt; C J Keemink
Journal: J Neurol Neurosurg Psychiatry Date: 1989-03 Impact factor: 10.154

3. Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations.

Authors: V Leuzzi; S Rinalduzzi; F Chiarotti; P Garzia; G Trasimeni; N Accornero
Journal: J Inherit Metab Dis Date: 1998-06 Impact factor: 4.982

4. Selective effects of low doses of apomorphine on spatiotemporal contrast sensitivity in healthy volunteers: a double-blind placebo-controlled study.

Authors: O Blin; D Mestre; G Masson; G Serratrice
Journal: Br J Clin Pharmacol Date: 1991-11 Impact factor: 4.335

Review 5. Retinopathy in Parkinson Disease.

Authors: Ivan Bodis-Wollner
Journal: J Neural Transm (Vienna) Date: 2009-11 Impact factor: 3.575

10. Schizophrenia spectrum participants have reduced visual contrast sensitivity to chromatic (red/green) and luminance (light/dark) stimuli: new insights into information processing, visual channel function, and antipsychotic effects.

Authors: Kristin S Cadenhead; Karen Dobkins; Jessica McGovern; Kathleen Shafer
Journal: Front Psychol Date: 2013-08-20

Contrast sensitivity in Parkinson's disease.

1. Bayesian adaptive estimation of the contrast sensitivity function: the quick CSF method.

2. Visual contrast sensitivity in drug-induced Parkinsonism.

3. Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations.

4. Selective effects of low doses of apomorphine on spatiotemporal contrast sensitivity in healthy volunteers: a double-blind placebo-controlled study.

Review 5. Retinopathy in Parkinson Disease.

6. Towards a classification of visual impairment.

Review 7. Are patients with Parkinson's disease blind to blindsight?

8. Contrast Acuity With Different Colors in Parkinson's Disease.

9. Driving under low-contrast visibility conditions in Parkinson disease.

10. Schizophrenia spectrum participants have reduced visual contrast sensitivity to chromatic (red/green) and luminance (light/dark) stimuli: new insights into information processing, visual channel function, and antipsychotic effects.